Osamu Nureki

Fundador en MODALIS THERAPEUTICS CORPORATION .

Fortuna: 1 M $ al 30/04/2024

58 años

Health Technology

Consumer Services

Perfil

Osamu Nureki is the founder of Modalis Therapeutics Corp., which was founded in 2016.
He holds the title of Outside Director at the company.
He is also currently working as an Outside Director at Curreio, Inc. since 2019.
Additionally, he has been a Professor at the University of Tokyo since 2008.
Dr. Nureki completed his undergraduate and graduate degrees at the University of Tokyo.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
MODALIS THERAPEUTICS CORPORATION 6.16%	31/12/2023	2 266 100 ( 6.16% )	1 M $	30/04/2024

Cargos activos de Osamu Nureki

Empresas	Cargo	Inicio
MODALIS THERAPEUTICS CORPORATION	Fundador	01/01/2016
Curreio, Inc. Curreio, Inc. Pharmaceuticals: MajorHealth Technology Curreio, Inc. is a drug discovery startup company founded in August 2019 and based in Tokyo, Japan. The Japanese company specializes in cryo-EM structural analysis technology and has unique technologies and know-how in protein production and purification, grid preparation, and 3D structural analysis. Curreio is currently developing internal/collaborative drug discovery projects and drug discovery support services for pharmaceutical companies using their cryo-EM technologies. The company's goal is to expand the possibilities of drug discovery for challenging proteins and protein-supramolecular complexes through structural analysis. The CEO is Motoki Nakai.	Director/Miembro de la Junta	01/11/2019
University of Tokyo	Corporate Officer/Principal	01/04/2008

Todos los cargos activos de Osamu Nureki

Formación de Osamu Nureki.

University of Tokyo

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Osamu Nureki.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
MODALIS THERAPEUTICS CORPORATION	Health Technology

Empresas privadas	1
Curreio, Inc. Curreio, Inc. Pharmaceuticals: MajorHealth Technology Curreio, Inc. is a drug discovery startup company founded in August 2019 and based in Tokyo, Japan. The Japanese company specializes in cryo-EM structural analysis technology and has unique technologies and know-how in protein production and purification, grid preparation, and 3D structural analysis. Curreio is currently developing internal/collaborative drug discovery projects and drug discovery support services for pharmaceutical companies using their cryo-EM technologies. The company's goal is to expand the possibilities of drug discovery for challenging proteins and protein-supramolecular complexes through structural analysis. The CEO is Motoki Nakai.	Health Technology